15 active trials 7 recruiting 4 Phase 3 4 disease areas
| Phase 2 | 10 | |
| Phase 2/3 | 1 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06937905 | Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced… | Neuroendocrine Carcinoma | Recruiting | 2026-02-11 |
| NCT06908993 | Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small… | Advanced Non Small Cell Lung Cancer | Recruiting | 2025-12-17 |
| NCT03977194 | Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving… | Non Small Cell Lung Cancer Metastatic | Active, Not Recruiting | 2025-11-18 |
| Phase 2/3 | ||||
| NCT05255302 | De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients… | Metastatic NSCLC | Recruiting | 2025-04-01 |
| Phase 2 | ||||
| NCT06656598 | Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in… | Stage III NSCLC | Recruiting | 2026-08-11 |
| NCT07234058 | Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus… | Pleural Mesotheliomas | Recruiting | 2026-08-11 |
| NCT06840834 | Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose… | Pleural Mesotheliomas | Recruiting | 2026-08-10 |
| NCT07759492 | Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage III Unresectable | Not Yet Recruiting | 2026-08-12 |
| NCT04526782 | ENCOrafenib With Binimetinib in bRAF NSCLC | Non Small Cell Lung Cancer | Active, Not Recruiting | 2026-08-11 |
| NCT05856695 | Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease… | Small Cell Lung Cancer Extensive Stage | Active, Not Recruiting | 2026-08-11 |
| NCT07420439 | Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung… | Non Small Cell Lung Cancer Metastatic | Not Yet Recruiting | 2026-08-11 |
| NCT05781308 | Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC… | Non Small Cell Lung Cancer | Active, Not Recruiting | 2025-11-18 |
| NCT05200481 | Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in… | Non Small Cell Lung Cancer | Active, Not Recruiting | 2025-11-17 |
| NCT04621188 | Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC… | Non Small Cell Lung Cancer Metastatic | Active, Not Recruiting | 2025-09-24 |
| Not applicable | ||||
| NCT06053099 | A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance… | Non Small Cell Lung Cancer | Recruiting | 2024-03-08 |
Non-Small Cell Lung Cancer (NSCLC) (11) · Lung Cancer (10) · Mesothelioma (2) · Small Cell Lung Cancer (1)